Tracking risk in integrated Alzheimer's diagnosis
Part of Brain & nervous system, Mental health clinical trials.
This study is looking for people with or at risk for Alzheimer's disease and their caregivers. It aims to track risk factors and improve diagnosis using a combination of tests and tools.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older.
- You have a main caregiver, like a family member or friend, who has been helping you for at least 6 months.
- Both you and your caregiver can understand the study and agree to take part.
- You do not have other serious brain or nerve disorders (like a recent stroke, brain tumor, or Parkinson's).
- You do not have untreated major depression, schizophrenia, or a history of alcohol or drug abuse.
- You are not in another Alzheimer's drug trial or have taken anti-amyloid drugs in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at sleep problems in people with mild Alzheimer’s disease and whether sleep measurements and questionnaires can help researchers understand early changes. You may be able to join if your diagnosis is mild and you can complete repeated sleep and thinking questionnaires with a family caregiver’s help.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study screens people aged 60–80 for early signs of Alzheimer's disease in a community setting. Researchers will ask you questions and may perform brain imaging to understand who might benefit from early detection and treatment.
This is a study that enrolls people with mild Alzheimer’s-related memory problems or dementia to help build a research “neurobank.” It also involves memory testing and may include brain scans, with a stable caregiver to support follow-up.
This study at Duke University is looking for people aged 25 to 80 who may be at risk for Alzheimer's disease. It involves brain scans (MRI and PET) and a spinal tap to learn more about the disease and find better ways to detect and treat it early.
This study uses a digital tool to help detect early signs of Alzheimer's disease in people aged 50 and older. It aims to find high-risk individuals who may benefit from early monitoring.
Hear when a new Cognitive Decline trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.